Lifeboat Foundation

Nice.

(NaturalNews) A diagnosis of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, was once considered a death sentence, but advanced automation technology is offering new hope to sufferers of the rare condition.

Most ALS patients eventually face an extremely difficult choice: either die from the lack of ability to breathe once the disease progresses or undergo a tracheostomy and spend the rest of one’s life on a ventilator – unable to move or speak.

Continue reading “Man suffering from ALS creates home electronic automation system that uses eye movement and brain waves” »

Some of the most famous artists in history may have left subtle clues to brain disease in their work, scientists have found.

A man with deadly brain cancer that had spread to his spine saw his tumors shrink and, for a time, completely vanish after a novel treatment to help his immune system attack his disease — another first in this promising field.

The type of immunotherapy that 50-year-old Richard Grady received already has helped some people with blood cancers such as leukemia. But the way he was given it is new, and may allow its use not just for brain tumors but also other cancers that can spread, such as breast and lung.

Grady was the first person to get the treatment dripped through a tube into a space in the brain where spinal fluid is made, sending it down the path the cancer traveled to his spine.

Continue reading “Cells dripped into brain help fight a deadly cancer” »

Research from Linda Griffith’s laboratory group at MIT will be presented at SPIE Photonics West 2017.

The traditional path for most drugs is to start in a petri dish containing a single cell tissue culture, move to small animals such as rodents then on to primates, and finally on to clinical trials in humans. Along the path, every step could encounter results that deem the drug a failure and not suitable for the desired outcome.

In Brief

• Researchers have created a 3D bulk material from silk fibroin that can be programmed to activate specific tasks when exposed to conditions like temperature or infrared light.
• The material could be used to create everything from hormone-emitting orthopedics to surgical pins that change color when they near their mechanical limits.

Engineers from Tufts University have just created a new, versatile material that could be optimized for a number of purposes, particularly within the medical field. The material was constructed out of special proteins called silk fibroins, and it can be programmed for specific biological, chemical, or mechanical tasks. The study was published online in Proceedings of the National Academy of Sciences (PNAS).

The team used water-based fabrication methods inspired by protein self-assembly to produce 3D bulk materials from silk fibroin. Fibroin, the structural protein that gives silk its durability, was chosen because it allowed for the easiest manipulation of the resulting substance’s form, as well as smoother modification of function. It’s also completely biodegradable.

Continue reading “Biotech Breakthrough: Engineers Made a New Material That Can Be Programmed” »

A Harvard research team led by biologist Douglas Melton has retracted a promising research paper following multiple failed attempts to reproduce the original findings.

Luv this.

Tufts University engineers have created a new format of solids made from silk protein that can be preprogrammed with biological, chemical, or optical functions, such as mechanical components that change color with strain, deliver drugs, or respond to light, according to a paper published online this week in Proceedings of the National Academy of Sciences (PNAS).

Using a water-based fabrication method based on protein self-assembly, the researchers generated three-dimensional bulk materials out of silk fibroin, the protein that gives silk its durability. Then they manipulated the bulk materials with water-soluble molecules to create multiple solid forms, from the nano- to the micro-scale, that have embedded, pre-designed functions.

Continue reading “Researchers Develop Preprogrammed Silk-Based Solid Materials with Pre-Designed Functions” »

Well before the family came in to the Batson Children’s Specialty Clinic in Jackson, Mississippi, they knew something was wrong. Their child was born with multiple birth defects, and didn’t look like any of its kin. A couple of tests for genetic syndromes came back negative, but Omar Abdul-Rahman, Chief of Medical Genetics at the University of Mississippi, had a strong hunch that the child had Mowat-Wilson syndrome, a rare disease associated with challenging life-long symptoms like speech impediments and seizures.

So he pulled out one of his most prized physicians’ tools: his cell phone.

Using an app called Face2Gene, Abdul-Rahman snapped a quick photo of the child’s face. Within a matter of seconds, the app generated a list of potential diagnoses — and corroborated his hunch. “Sure enough, Mowat-Wilson syndrome came up on the list,” Abdul-Rahman recalls.

Continue reading “How machine learning Is revolutionizing the diagnosis of rare diseases” »

PanARMENIAN.Net — In the future, getting customized cancer treatments might just be a matter of injecting virtually invisible discs into your body, Engadget said.

University of Michigan scientists have had early success testing 10nm “nanodiscs” that teach your body to kill cancer cells. Each disc is full of neoantigens, or tumor-specific mutations, that tell your immune system’s T-cells to recognize those neoantigens and kill them. When you pair them up with immune checkpoint inhibitors (which boost the T-cells’ responses), they can not only wipe out existing tumors, but prevent them from reemerging later.

This testing has been limited to mice so far, but it’s promising. The nanodiscs took 10 days to eliminate tumors, and they shut down identical tumors when they were reinserted 70 days later. For the researchers, the big challenge right now is scaling the tests to see if they still hold up with larger animals. If the approach proves successful with humans, the days of generic cancer solutions might be limited — so long as doctors could get a sample of your cancer, they’d stand a realistic chance of eliminating the disease, Engadget said.